You may also like
X Technologies Wins U.S. Nod for Heart Device, Clearing the Way for Acquisition by Guidant
NEW YORK (Reuters Health) – Privately held X Technologies Inc. has won U.S. marketing clearance for a new device, fulfilling the conditions […]
1 min read
Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
Hypercoagulability and secondary hyperfibrinolysis during ECMO support in COVID-19 patients are common and possibly increase the propensity for thrombotic events and failure of the oxygenator. Currently, there is not enough evidence to support a more aggressive anticoagulation strategy.
1 min read
Cold Blood Cardioplegia Versus Cold Crystalloid Cardioplegia: A Prospective Randomized Study of 1440 Patients Undergoing Coronary Artery Bypass Grafting
There were no significant differences whether myocardial protection was performed with cold blood cardioplegia or cold crystalloid cardioplegia during aortic crossclamping in patients undergoing coronary artery bypass grafting.
1 min read